Jetstar drops $130 Asia flights in new sale
Starting from noon for Club Jetstar members and midnight for the public, travellers can catch a one-way flight to Tokyo, Osaka and Seoul for a much-needed getaway.
Residents in Cairns can catch a one-way flight to Tokyo (Narita) or Osaka (Kansai) from $130, with flights from Brisbane to Osaka or Seoul (Incheon) starting at $155.
Further south on the east coast, travellers can catch a direct one-way flight from Sydney to Osaka from $165 and Seoul from $170 or from Sydney to Tokyo via Cairns for $253.
Travel dates vary per route but include flights from October 2025 to May 2026.
People can sign up to be a Jetstar Club member for $65.
Jetstar's sale ends at 11.59pm AEST on Thursday, July 24 unless sold out prior. Sale prices do not include checked baggage.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Philip Morris' shares slip in pre-market trading on quarterly revenue miss
(Reuters) -Marlboro-maker Philip Morris International (PMI) on Tuesday reported second-quarter revenue behind expectations as cigarette sales slipped and shipments of its ZYN nicotine pouches fell short of forecasts. Shares in the world's largest tobacco company by market capitalisation dropped about 5% in premarket trading. PMI has been faster than its peers to transition from traditional tobacco products to smoking alternatives, such as ZYN, the rapid growth of which has seen it become PMI's star product. Cigarettes, however, remain the main engine of PMI's business, and are in decline. PMI also faces regulatory headwinds and tough economic conditions have hit consumers' wallets. While PMI's total sales rose 7.1% to $10.14 billion in the latest quarter, they fell short of analysts' average estimate of $10.33 billion, as per data compiled by LSEG. Shipment volumes in its cigarettes business declined 1.5%, while, in contrast, volumes in PMI's nicotine pouch business rose 23.8%. ZYN shipments of 190 million cans were behind the 203 million expected by analysts, Bernstein's Callum Elliot said in a note, adding that PMI's strong performance in recent quarters has led investors to set high expectations. "These numbers risk being not quite 'good enough' for the higher bar that PMI is likely to be held to today," he wrote. PMI also saw steady growth in inhalable alternative nicotine products, notably its flagship heated tobacco device IQOS, across Europe and Japan and cities such as Jakarta, Mexico and Seoul. Earlier this year, PMI began selling IQOS on a small scale in the United States, a move that ultimately is expected to help fuel its push to diversify revenue streams beyond cigarettes. The company aims to generate half of its sales from smoking alternatives by the end of 2025. Its second-quarter adjusted profit of $1.95 per share beat market estimates of $1.86 per share. It expects an adjusted profit of $7.43 to $7.56 per share for the year, compared with its prior forecast of $7.36 to $7.49. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Philip Morris's revenue misses estimates as cigarette volumes drop
(Reuters) -Philip Morris International (PMI), which makes Marlboro cigarettes, reported second-quarter revenue on Tuesday that fell short of analysts' estimates as cigarette sales volumes slipped. The company's shares dropped about 5% in premarket trading. While PMI has been faster than its peers to transition from traditional tobacco products to smoke-free alternatives, such as its flagship heated tobacco device IQOS and nicotine pouch brand ZYN, it is still grappling with sharp declines in tobacco use. Tobacco products, including cigarettes, are still the main engine of PMI's business, and besides competition from smoke-free products, regulatory headwinds and tough economic conditions have hit consumers' wallets. As a result, while PMI's total sales rose 7.1% to $10.14 billion in the latest quarter, it fell short of analysts average estimate of $10.33 billion, as per data compiled by LSEG. Shipment volumes in its cigarettes business declined 1.5%, while, in contrast, volumes in oral smoke-free products business rose 23.8%. PMI saw steady growth in inhalable alternative nicotine products, notably of IQOS, across Europe and Japan and cities such as Jakarta, Mexico and Seoul. Earlier this year, PMI began selling IQOS on a small scale in the United States, a move that ultimately is expected to help fuel its push to diversify revenue streams beyond cigarettes. In the fast-growing nicotine pouches market, PMI's ZYN is already a U.S. market leader. PMI, whose shift from cigarettes has been faster than rivals Altria and BATS, aims to generate half of its sales from smoking alternatives by the end of 2025. The company's second-quarter adjusted profit of $1.95 per share beat market estimates of $1.86 per share. It expects an adjusted profit of $7.43 to $7.56 per share for the year, compared with its prior forecast of $7.36 to $7.49. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Lindt sweetens sales forecast after 'strong' H1
Swiss chocolatier Lindt & Sprüngli has raised its sales forecast for 2025 after 'strong' growth in the first half of 2025. The Lindor maker now projects its sales will rise by 9-11% on an organic basis this year, up from its previous forecast of 7–9%. In a statement issued today (22 July), Lindt & Sprüngli said its positive outlook is underpinned by "continued consumer loyalty and the ongoing trend towards premiumisation". Lindt & Sprüngli is forecasting an increase in EBIT margin at the "lower end of" its medium-term annual target of growth of 20 to 40 basis points for 2025. The first half of the year saw Lindt & Sprüngli grow its organic sales growth by 11.2%, amounting to total sales of Sfr2.35bn ($2.94bn). The increase was driven by all regions, the company said, with Europe leading the way with a "very strong" organic sales growth of 17.7%. All European subsidiaries reported "double-digit growth", with the 'strongest' performances observed in the Nordics, Benelux, Central Eastern Europe, France and Austria. In North America, Lindt & Sprüngli's organic sales grew by 3.6% by the business said the result fell short of expectations as a result of 'weak consumer sentiment'. Conversely, the Rest of the World division saw sales rise 7.8%, with Japan, Brazil, South Africa, and China recording "double-digit growth". EBIT fell 11.3% to Sfr259.2m. In the first half of 2024, Lindt & Sprüngli generated EBIT of Sfr292.3m, which included a one-off effect from a resolved legal dispute. Net income declined 13.3%, settling at Sfr188.9m. The company reported a negative free cash flow of Sfr79.7m in the first half of the year, compared with a positive Sfr70.4m in the corresponding period of 2024, influenced by the "higher valuation of inventories because of the higher cocoa costs". In response to the escalating cocoa prices, Lindt & Sprüngli announced in March its intention to implement double-digit price increases in 2025, following a 6.3% hike initiated last year. CEO Dr Adalbert Lechner, while presenting Lindt's 2024 financial results on 4 March, refrained from specifying the exact figure for the impending cocoa-linked price increases but acknowledged that the rise was "significant". "Lindt sweetens sales forecast after 'strong' H1" was originally created and published by Just Food, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
